Walgreen has also been investing heavily in the specialty-pharmacy space. This is highlighted by its acquisition of BioScrip Inc (NASDAQ:BIOS)’s specialty pharmacy unit in 2012, a niche area that focuses on the most chronically ill members of the population. BioScrip Inc (NASDAQ:BIOS) stock opened at $7.10 in last session, and closed at $7.34, while the day range of BIOS stock is $7.08 – $7.35. The stock showed a positive weekly performance of 1.94%.
Amedisys Inc. (NASDAQ:AMED), one of the country’s largest home health companies, reported a fourth-quarter loss of $9.6 million, or 30 cents per share, compared with a $106.8 million loss, or $3.52 per share, a year ago. Amedisys Inc (NASDAQ:AMED) stock opened at $14.52, in last session and closed at $15.42, by losing -1.53%. The 52 week range of AMED is $8.81 – $18.70. Company’s market capitalization is $500.54million.
Gentiva Health Services, Inc. (NASDAQ:GTIV)’s dismal fourth-quarter 2013 financial results and the rating agency’s projection of continued challenges from unfavorable industry headwinds and operating missteps impelled Moody’s to lower the outlook. Gentiva Health Services, Inc. (NASDAQ:GTIV) stock advanced 1.37% and finished the last session at $8.89. The EPS of the stock remained -6.13. Company’s market capitalization is $323.37million.
Chemed Corp. (NYSE:CHE) EVP Timothy S. Otoole sold 6,000 shares of the stock in a transaction dated Tuesday, March 11th. Chemed Corporation (NYSE:CHE) stock opened the session at $86.20, and closed the session at $86.13. The 52 week range of the CHE stock remained $61.68 – $87.43 and the day range was $85.84 – $86.71.